article thumbnail

Teknova unveils new manufacturing facility for high-quality reagents

BioPharma Reporter

Teknova, a producer of life science reagents, has opened a new GMP-certified production facility which it claims will enable bioprocessing and gene therapy companies to get into the clinic faster.

Reagent 98
article thumbnail

Global Research Antibodies and Reagents Market Forecasts, 2020-2027: Focus on Antibodies, Production, Source, Research Area, Reagents, ELISA, Western Blot – ResearchAndMarkets.com

BioTech 365

Global Research Antibodies and Reagents Market Forecasts, 2020-2027: Focus on Antibodies, Production, Source, Research Area, Reagents, ELISA, Western Blot – ResearchAndMarkets.com Global Research Antibodies and Reagents Market Forecasts, 2020-2027: Focus on Antibodies, Production, Source, Research Area, Reagents, ELISA, Western Blot … Continue (..)

Reagent 40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How single-use technologies can improve antibodies production  

Drug Discovery World

Where the bottlenecks of achieving higher cell density and higher titers were once thought to be issues of the past, hurdles have now shifted to achieving speed and scale in mAb production without sacrificing quality. DC: Antibodies have and remain a large product class within the biopharmaceutical market.

article thumbnail

The latest drug discovery product launches

Drug Discovery World

Several new products for the life sciences sector have been launched over the last month, from miniature semiconductor chip (MSC) technology to a new inhalation testing service. The platform works with the SYNTAX Hi-Fidelity reagent kits for synthesising longer oligos. DDW provides an update.

article thumbnail

MIP Discovery raises £7m to drive commercialization in cell and gene space

BioPharma Reporter

MIP Discovery, a developer of non-biological affinity reagents designed to accelerate the production of cell and gene therapies, has closed a Â7 million Series A financing round, led by Mercia Ventures.

Gene 97
article thumbnail

Polyplus launches transfection reagent for large scale viral vector production

BioPharma Reporter

Recombinant adeno-associated viruses (rAAVs) are becoming the vector of choice for delivering gene therapies, says the French firm.

Reagent 98
article thumbnail

Global Gene Expression Market Size, Share & Trends Analysis 2021-2028 by Product (DNA Chip/Microarray, Kits & Reagents), Technique (Promoter Analysis, RNA Exp.) – ResearchAndMarkets.com

BioTech 365

Global Gene Expression Market Size, Share & Trends Analysis 2021-2028 by Product (DNA Chip/Microarray, Kits & Reagents), Technique (Promoter Analysis, RNA Exp.) – ResearchAndMarkets.com Global Gene Expression Market Size, Share & Trends Analysis 2021-2028 by Product (DNA Chip/Microarray, Kits & … Continue reading → (..)